KrankenbergHSchlüterMSteinkampHJ. Nitinol stent implantation versus percutaneous translumen angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral stenting trial (FAST). Circulation. 2007;116:285–292.
2.
LairdJRKatzenBTScheinertD. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv. 2010;3:267–276.
3.
DickPWallnerHSabetiS. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Catheter Cardiovasc Interv. 2009;74:1090–1095.
4.
DakeMDAnselGMJaffMR. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX Randomized study results. Circ Cardiovasc Interv. 2011;4:495–504.
5.
DakeMDScheinertDTepeG.; Zilver PTX Single-Arm Study Investigators. Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: twelve-month safety and effectiveness results from the Zilver PTX single-arm clinical study. J Endovasc Ther. 2011;18:613–623.
6.
BosiersMPeetersPTessarekJ. The Zilver PTX Zilver single arm study: 12-month results from the TASC C/D lesion subgroup. J Cardiovasc Surg. 2013;54:115–122.
7.
ZellerTRastanAMacharzinaR. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions. J Endovasc Ther. 2014;21:359–368.
8.
AkiyamaTMoussaIReimersB. Angiographic and clinical outcome following coronary stenting of small vessels: a comparison with coronary stenting of large vessels. J Am Coll Cardiol. 1998;32:1610–1618.
9.
EleziSKastratiANeumannFJ. Vessel size and long-term outcome after coronary stent placement. Circulation. 1998;98:1875–1880.
10.
WitzenbichlerBMaeharaAWeiszG.Relationship between intravascular ultrasound guidance and clinical outcomes after drug eluting stents. Circulation. 2014;129:463–470.
ArkoFMcColloughRManningL.Use of Intravascular ultrasound in the management of atherosclerotic aortoiliac occlusive disease. Am J Surg. 1996;172:546–549.
13.
IidaOTakaharaMSogaY. Efficacy of intravascular ultrasound in femoropopliteal stenting for peripheral artery disease with TASC II class A to C lesions. J Endovasc Ther. 2014;21:485–492.
14.
MikiKFujiiKFukunagaM. Impact of post-procedural intravascular ultrasound findings on long-term results following self-expanding nitinol stenting in superficial femoral artery lesions. Circ J. 2013;77:1543–1550.
15.
MoriSHiranoKNakanoM. Intravascular ultrasound measurements after drug-eluting stent placement in femoropopliteal lesions: determining predictors of restenosis. J Endovasc Ther. 2015;22:341–349.
16.
StavroulakisKDonasKPTorselloG. Gender-related long-term outcome of primary femoropopliteal stent placement for peripheral artery disease. J Endovasc Ther. 2015;22:31–37.
